Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

AMBISOME APPROVED FOR SALE IN MEXICO, ITALY

Oct. 31, 1991

ENVIROGEN COMPLETES FINANCING ROUND

Oct. 31, 1991

CHIRON-CETUS VOTE DEC. 10

Oct. 30, 1991

FDA APPROVES BLOOD SUBSTITUTE TESTS

Oct. 30, 1991

ALLIANCE IMAGING AGENT ENTERS PHASE I

Oct. 30, 1991

CAL BIO RAISES $56.9 MILLION IN OFFERING

Oct. 30, 1991

ANALYST UPGRADES IMMUNEX RATING

Oct. 30, 1991

MAGAININ FILES FOR 2 MILLION-SHARE IPO

Oct. 30, 1991

IMMUNE RESPONSE RAISES $44 MILLION

Oct. 30, 1991

GENENTECH SEEKS BUYER FOR GLC ASSOCIATES

Oct. 30, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...